Role of Neutrophils and Lymphocytes in Inhibition of a Mouse Mammary Adenocarcinoma Engineered to Release IL-2, IL-4, IL-7, IL-10, IFN-α, IFN-γ, and TNF-α

Laboratory Investigation

Volumn 74, Issue 1, 1996, Pages 146-157

  Musiani, Piero ^a,e   Allione, Alessandra ^f   Modica, Alessandro ^a   Lollini, Pier Luigi ^d   Giovarelli, Mirella ^b   Cavallo, Federica ^b   Belardelli, Filippo ^c   Forni, Guido ^b   Modesti, Andrea ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Ospedale SS Annunziata   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER IMMUNOLOGY; CANCER INHIBITION; CARCINOGENICITY; FEMALE; GENETIC TRANSDUCTION; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYTOKINES; FEMALE; GENETIC ENGINEERING; IMMUNOSUPPRESSION; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-7; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEUTROPHILS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030033708     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Allione A, Consalvo M, Nanni P, Lollini PL, Cavallo F, Giovarelli M, Forni M, Gulino A, Colombo MP, Dellabona P, and Forni G (1994). Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL 1994;2, IL4, IL6, IL7, IL10, TNFa, GM-CSF, and IFNg gene or admixed with conventional adjuvants. Cancer Res 54:6022-6026.
2. Blankenstein T, Rowley DA, and Schreiber H (1991). Cytokines and cancer: Experimental systems. Curr Opin Immunol 3:694-698.
3. Cavallo F, Giovarelli M, Gulino A, Vacca A, Stoppacciaro A, Modesti A, and Forni G (1992). Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene transfection. J Immunol 149: 3627-3635.
4. Cavallo F, Colombo MP, Allione A, Bertini S, Consalvo M, Novelli F, and Giovarelli M (1994). Antitumor responses elicited by mouse adenocarcinoma cells engineered to release IL-2 and IL-4. In: Forni G, Foa R, Santoni A, and Frati L, editors. Cytokine-induced tumor immunogenicity: From exogenous molecules to gene therapy. London: Academic Press, 203-216.
5. Colombo MP, Modesti A, Parmiani G, and Forni G (1992). Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T lymphocyte crosstalk. Cancer Res 52:4853-4857.
6. Colombo MP and Forni G (1994). Cytokine gene transfer in tumor inhibition and tentative tumor therapy: Where are we now? Immunol Today 15:48-51.
7. Del Pozo V, De Andres B, Martin E, Cardaba B, Fernandez JC, Gallardo S, Tramon P, Leyva-Cobian F, Palomino P, and Lahoz C (1992). Eosinophil as antigen presenting cell: Activation of T cell clones and T cell hybridoma by eosinophils after antigen processing. Eur J Immunol 22:1919-1925.
8. Djeu JY, Liu H, Wei S, Rui H, Pearson CA, Leonard WJ, and Blanchard DK (1993). Function associated with IL-2 receptor b on human neutrophils. J Immunol 150:960-970.
9. Erard F, Wild MT, Garcia-Sanz JA, and Le Gros G (1993). Switch of CD8+ T cells to noncytolytic CD8- CD4- cells that make Th2 cytokines and help B cells. Science 260:1802-1805.
10. Ferrantini M, Giovarelli M, Modesti A, Musiani P, Modica A, Venditti M, Peretti E, Lollini PL, Nanni P, Forni G, and Belardelli F (1994). IFN-α gene expression into a metastatic murine adenocarcinoma (TS/A) results in CD8+ T cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-γ producing TS/A cells. J Immunol 153:4604-4615.
11. Forni G, Foa R, Santoni A, and Frati L, editors (1994). Cytokine-induced tumor immunogenicity: From exogenous molecules to gene therapy. London: Academic Press.
12. Giovarelli M, Musiani P, Modesti A, Dellabona P, Casorati G, Allione A, Consalvo M, Cavallo F, Di Pierro F, De Giovanni C, Musso T, and Forni G (1995). The local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress the enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody dependent immune memory. J Immunol 155: 3112-3123.
13. Gosselin EJ, Wardwell K, Rigby WFC, and Guyre PM (1993). Induction of MHC class II on human polymorphonuclear neutrophils by granulocyte macrophage colony-stimulating factor, IFN-g, and IL-1993;3. J Immunol 151:1482-1490.
14. Kapp A and Zeck-Kapp G (1990). Activation of the oxidative metabolism in human polymorphonuclear neutrophilic granules: The role of immunomodulating cytokines. J Invest Dermatol 95:94S.
15. Kudo C, Yamashita T, Araki A, Terashita M, Watanabe T, Atsumi M, Tamura M, and Sendo F (1993). Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. J Immunol 150:3728-3738.
16. Lloyd AR and Oppenheim JJ (1992). Poly's lament: The neglected role of the polymorphonuclear neutrophil in the efferent limb of the immune system. Immunol Today 13:169-172.
17. Lollini PL, Bosco MC, Cavallo F, De Giovanni C, Giovarelli M, Landuzzi L, Musiani P, Modesti A, Nicoletti G, Palmieri G, Santoni A, Young HA, Forni G, and Nanni P (1993). Inhibition of tumor growth and enhancement of metastasis after transfection of the g-Interferon gene. Int J Cancer 55:320-329.
18. Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, and Colombo MP (1995). CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur J Immunol 25:137-146.
19. Midorikawa Y, Yamashita T, and Sendo F (1990). Modulation of the immune response to transplantation tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody. Cancer Res 50:6243-6247.
20. Modesti A, Musiani P, Cortesina G, and Forni G (1994). Cytokine dependent tumour recognition. In: Forni G, Foa R, Santoni A, and Frati L, editors. Cytokine-induced tumor immunogenicity: From exogenous molecules to gene therapy. London: Academic Press, 55-68.
21. Mossmann TR and Coffmann RL (1989). TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
22. Musiani P, Modesti A, Brunetti M, Modica A, Gulino A, Bosco MC, Colombo MP, Nanni P, Cavallo F, Pericle F, Giovarelli M, Cavallo R, and Forni G (1994). The nature and potential of the reactive response to mouse mammary adenocarcinoma cells engineered with IL-2, IL-4 or IFN-g gene. Nat Immun 13:93-101.
23. Nanni P, De Giovanni C, Lollini PL, Nicoletti G, and Prodi G (1983). TS/A: A new metastatizating cell line originated from a BALB/c spontaneous mammary adenocarcinoma. Clin Exp Med 1:373-380.
24. Nathan C and Sporn MJ (1991). Cytokines in context. J Cell Biol 113:981-986.
25. Pardoll DM (1992). New strategies for active immunotherapy with genetically engineered tumor cells. Curr Opin Immunol 4:619-623.
26. Pericle F, Giovarelli M, Colombo MP, Ferrari G, Musiani P, Modesti A, Cavallo F, Di Pierro F, Novelli F, and Forni G (1994a). An efficient Th-2-type memory follows CD8+ lymphocyte driven and eosinophil mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol 153:5659-5673.
27. Pericle F, Liu JH, Diaz JI, Blanchard DK, Wei S, Forni G, and Djeu JY (1994b). Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 24:440-444.
28. Pickaver AH, Ratcliffe NA, Williams AE, and Smith H (1972). Cytotoxic effects of peritoneal neutrophils on a syngeneic rat tumor. Nature New Biol 235:186-187.
29. Robbins SL, Cotran RS, and Kumar V, editors (1994). Pathologic basis of disease, 5th ed. Philadelphia: Saunders, 14-19, 57-60.
30. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, and Bloom BR (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-282.
31. Seder RS and Paul WE (1994). Acquisition of lymphokine-production phenotype by CD4+ T cells. Ann Rev Immunol 12:635-673.
32. Shau H (1988). Characteristics and mechanisms of neutrophil-mediated cytostasis induced by tumor necrosis factor. J Immunol 141:234-240.
33. Stoppacciaro A, Forni G, and Colombo MP (1994). Different tumors transduced with different cytokine genes as G-CSF and IL-2 show inhibition of take through neutrophil activation but differ in T cell functions. Folia Biol (Praha) 40:89-99.
34. Tepper RI and Mulé JJ (1994). Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153-164.
35. Vecchi A, Garlanda C, Lampugnani MG, Resnati M, Matteucci C, Stoppacciaro A, Schnurch H, Risau W, Ruco L, Mantovani A, and Dejana B (1994). Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur J Cell Biol 63:247-254.